32 phenotypes from 2 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Abcb1amds/Abcb1amds involves: CF-1	abnormal hippocampus CA3 region morphology	J:64725
	catalepsy	J:64725
	hippocampal neuron degeneration	J:64725
	increased eosinophil cell number	J:64725
	increased physiological sensitivity to xenobiotic	J:40292, J:64725
	premature death	J:64725
	tremors	J:64725
Abcb1atm1Bor/Abcb1atm1Bor FVB.129P2-Abcb1atm1Bor/TacImx	abnormal intestinal epithelium morphology	J:51190
	abnormal intestinal mucosa morphology	J:51190
	abnormal large intestine crypts of Lieberkuhn morphology	J:51190
	abnormal lymphocyte physiology	J:51190
	cachexia	J:51190
	colitis	J:51190
	crypts of Lieberkuhn abscesses	J:51190
	increased IgA level	J:51190
	increased IgE level	J:51190
	increased IgG1 level	J:51190
	increased IgG2 level	J:51190
	increased IgG2a level	J:51190
	increased IgG2b level	J:51190
	increased IgG3 level	J:51190
	increased IgM level	J:51190
	increased immunoglobulin level	J:51190
	intestinal ulcer	J:51190
	large intestinal inflammation	J:51190
	mucous diarrhea	J:51190
Abcb1atm1Bor/Abcb1atm1Bor FVBTac.129P2-Abcb1atm1Bor	abnormal blood-inner ear barrier function	J:59145
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:102640
	abnormal xenobiotic pharmacokinetics	J:59145, J:102640
	decreased gamma-delta intraepithelial T cell number	J:102640
	increased physiological sensitivity to xenobiotic	J:59145
	increased susceptibility to ototoxicity-induced hearing loss	J:59145
Abcb1atm1Bor/Abcb1atm1Bor involves: 129P2/OlaHsd * FVB	abnormal xenobiotic pharmacokinetics	J:39804
	impaired blood-brain barrier function	J:18554
	increased physiological sensitivity to xenobiotic	J:18554